1,526
Views
2
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Is 18F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?

, , , , , & show all
Pages 244-247 | Received 12 Nov 2014, Accepted 20 May 2015, Published online: 24 Jun 2015

Figures & data

Figure 1. Patients’ selection flowchart. Note: BrCa, breast cancer; DCIS, ductal carcinoma in situ; HHUMC, Hadassah Hebrew University Medical Center; ILBrCa, invasive lobular breast cancer; IDBrCa, invasive ductal breast cancer.
Figure 1. Patients’ selection flowchart. Note: BrCa, breast cancer; DCIS, ductal carcinoma in situ; HHUMC, Hadassah Hebrew University Medical Center; ILBrCa, invasive lobular breast cancer; IDBrCa, invasive ductal breast cancer.
Figure 2. Axial views of 18F-FDG PET/CT show: (A and B) a highly intense focus (SUV max 10.5) (B) in a small lytic lesion in the left rib anteriorly (red cross); (C and D) a highly intense (SUV max 10) focus in a small lymph node in the left axilla (arrows); (E and F) an elongated pathological uptake (SUV max up to 13) in the peritoneal spread around the liver (red cross); (G and H) high accumulation of FDG (SUV max up to 14) in large implants in both ovary (red cross).
Figure 2. Axial views of 18F-FDG PET/CT show: (A and B) a highly intense focus (SUV max 10.5) (B) in a small lytic lesion in the left rib anteriorly (red cross); (C and D) a highly intense (SUV max 10) focus in a small lymph node in the left axilla (arrows); (E and F) an elongated pathological uptake (SUV max up to 13) in the peritoneal spread around the liver (red cross); (G and H) high accumulation of FDG (SUV max up to 14) in large implants in both ovary (red cross).

Figure 3. Kaplan-Meier survival curves for true positive (TP) and true negative (TN) scans. p-Value for Log-Rank = 0.005.

Figure 3. Kaplan-Meier survival curves for true positive (TP) and true negative (TN) scans. p-Value for Log-Rank = 0.005.
Supplemental material

ionc_a_1054952_sm3640.pdf

Download PDF (29 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.